PAVS happ.org.cn Company Net Income

Expansion risks for the Paranovus (PAVS) digital B2B organic platform are creating volatility reflected in the company's profit metrics. The -0.01 mark serves as a key figure for current dynamics. Stability is driven by the synthesis of biomedical technologies with nutraceuticals and the integration of AI modules into Chinese logistics. This technological stack is transforming cash flows, confirming the resilience of the chosen business development model.

happ.org.cn (PAVS) - Net Profit from 06/27/2023 to 10/30/2026

Analytical breakdowns and data insights for company Paranovus Entertainment Technology (PAVS)

- stock price and consensus target price:

Price Performance Chart happ.org.cn|PAVS - Price Target Chart

- market capitalization data:

Market Value Paranovus Entertainment Technology Inc.|PAVS - Real Price to Acquire Entire Company

- balance sheet equity data:

Book Price of a Share Paranovus|PAVS - Book Capitalization|Market Value to Book Value happ.org.cn|PAVS - Company Total Assets

- debt and solvency information:

Debt to Capital Paranovus|PAVS - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Paranovus Entertainment Technology Inc.|PAVS - Company Debts|Debts to Book Capitalization Ratio Paranovus Entertainment Technology Inc.|PAVS - Company Long-Term Debts|Company Short-Term Debts Paranovus|Intermediate Coverage Ratio happ.org.cn

- earnings and valuation multiples indicators:

PAVS - Net Profit

Basic company analysis:happ.org.cn PAVS

Rising demand for Paranovus (PAVS) natural nutraceuticals converts directly into net income, which measures the final business efficiency after deducting all operating and tax expenses. By analyzing the company's net income trends, an investor can objectively assess the fundamental return on the supplement accessibility strategy, confirming the stability of the asset's market value.

Direct competitors